Keyphrases
Germ Cell Tumor
100%
Mammalian Target of Rapamycin (mTOR)
100%
Novel Therapeutic Targets
100%
EGF Receptor
100%
Non-seminomatous Germ Cell Tumor (NSGCT)
100%
Seminoma
60%
MTORC1 Pathway
60%
MTORC1 Signaling
40%
Tumor Growth
20%
Older Adults
20%
Molecular Mechanism
20%
Yolk Sac Tumor
20%
Tumor Cells
20%
EGFR Signaling
20%
Differentiation State
20%
Tumor Differentiation
20%
Late Effects
20%
Clinical Behavior
20%
Mitogen-activated Protein Kinase
20%
Signaling Network
20%
Rapamycin
20%
Erlotinib
20%
Therapeutic Targeting
20%
Combined Treatment
20%
Clinical Response
20%
Malignant Tumor
20%
Negatively Regulate
20%
Pluripotent
20%
Response to Treatment
20%
Choriocarcinoma
20%
Nonseminoma
20%
Fibroblast Growth factor-2 (FGF-2)
20%
EGFR Pathway
20%
MAPK Signaling
20%
Cisplatin-based Regimen
20%
FGF Receptor
20%
REDD+
20%
Ther
20%
Embryonal Carcinoma
20%
Embryonic Germ Cells
20%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Tumor Progression
25%
Mitogen-Activated Protein Kinase
25%
Cisplatin
25%
Fibroblast Growth Factor Receptor
25%
MAPK Signaling
25%
Basic Fibroblast Growth Factor
25%
Erlotinib
25%